Table 2 Baseline characteristics by 3%ODI.

From: Sleep-disordered breathing profiles in patients with cardiovascular diseases: Kurume SDB-CVD study

All

3%ODI < 5

5 ≤ 3%ODI < 15

15 ≤ 3%ODI < 30

30 ≤ 3%ODI

P for trend

n (%)

2067 (35.9)

2426 (42.1)

975 (16.9)

297 (5.2)

 

Male/Female (Male,%)

1092/975 (52.8)

1495/931 (61.6)

704/271 (72.2)

232/65 (78.1)

 < 0.001

Age, years old

62.4 ± 16.8

67.6 ± 12.7

70.8 ± 11.2

70.9 ± 11.5

 < 0.001

SpO2 at awakening, %

95.1 ± 1.9

94.0 ± 2.0

93.2 ± 2.1

91.9 ± 3.3

 < 0.001

Systolic blood pressure, mmHg

121.5 ± 18.7

121.7 ± 18.8

122.6 ± 18.0

125.6 ± 18.5

0.002

Diastolic blood pressure, mmHg

70.9 ± 12.6

70.4 ± 12.8

70.4 ± 12.8

72.5 ± 13.1

0.589

Pulse pressure, mmHg

50.6 ± 15.5

51.3 ± 15.5

52.2 ± 15.9

53.1 ± 16.8

0.001

Pulse rate, bpm

72.9 ± 14.4

72.6 ± 14.3

72.2 ± 15.3

74.4 ± 15.4

0.871

BMI, kg/m2

22.3 ± 3.4

23.6 ± 3.6

24.6 ± 4.0

25.9 ± 5.1

 < 0.001

WBC, /μL

5791 ± 1876

6013 ± 2189

6092 ± 1924

6341 ± 1979

 < 0.001

Hb, g/dL

13.1 ± 1.9

13.2 ± 2.0

13.1 ± 2.1

13.3 ± 2.2

0.222

HbA1c, %

6.0 ± 0.8

6.1 ± 0.8

6.3 ± 0.9

6.4 ± 0.9

 < 0.001

Serum creatinin, mg/dL

1.13 ± 1.54

1.26 ± 1.74

1.36 ± 1.66

1.56 ± 1.88

 < 0.001

Serum sodium, mEq/L

140.6 ± 2.9

140.8 ± 2.8

140.6 ± 3.0

140.8 ± 2.6

0.767

NT-proBNP, pg/mL

2551 ± 11,155

2674 ± 13,191

3148 ± 13,353

5533 ± 202

0.004

CTR (chest X-ray), %

49.9 ± 7.6

51.3 ± 6.9

52.3 ± 6.8

53.8 ± 6.2

 < 0.001

LVEF, %

62.4 ± 13.5

60.7 ± 14.9

58.8 ± 15.4

55.2 ± 16.3

 < 0.001